These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16260325)

  • 1. Systematic review of economic analyses of health care-associated infections.
    Stone PW; Braccia D; Larson E
    Am J Infect Control; 2005 Nov; 33(9):501-9. PubMed ID: 16260325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of hospital-acquired infection and transferability of the estimates: a systematic review.
    Fukuda H; Lee J; Imanaka Y
    Infection; 2011 Jun; 39(3):185-99. PubMed ID: 21424853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis.
    Scott RD; Culler SD; Rask KJ
    J Infus Nurs; 2019; 42(2):61-69. PubMed ID: 30817421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and economic impact of health care-associated infections and cost-effectiveness of infection control measures at a Thai university hospital.
    Rattanaumpawan P; Thamlikitkul V
    Am J Infect Control; 2017 Feb; 45(2):145-150. PubMed ID: 27665034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections.
    Nelson RE; Schweizer ML; Perencevich EN; Nelson SD; Khader K; Chiang HY; Chorazy ML; Blevins A; Ward MA; Samore MH
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1212-8. PubMed ID: 27406609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the cost of health care-associated infections: mind your p's and q's.
    Graves N; Harbarth S; Beyersmann J; Barnett A; Halton K; Cooper B
    Clin Infect Dis; 2010 Apr; 50(7):1017-21. PubMed ID: 20178419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000.
    Stone PW; Larson E; Kawar LN
    Am J Infect Control; 2002 May; 30(3):145-52. PubMed ID: 11988708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic transmission models for economic analysis applied to health care-associated infections: A review of the literature.
    Nelson RE; Deka R; Khader K; Stevens VW; Schweizer ML; Rubin MA
    Am J Infect Control; 2017 Dec; 45(12):1382-1387. PubMed ID: 28958442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.
    Umscheid CA; Mitchell MD; Doshi JA; Agarwal R; Williams K; Brennan PJ
    Infect Control Hosp Epidemiol; 2011 Feb; 32(2):101-14. PubMed ID: 21460463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the costs of hospital-acquired infections in New Zealand.
    Graves N; Nicholls TM; Morris AJ
    Infect Control Hosp Epidemiol; 2003 Mar; 24(3):214-23. PubMed ID: 12683515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of healthcare-associated infection in US acute care hospitals: societal perspective.
    Marchetti A; Rossiter R
    J Med Econ; 2013 Dec; 16(12):1399-404. PubMed ID: 24024988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs associated with health care-associated infections in cardiac surgery.
    Greco G; Shi W; Michler RE; Meltzer DO; Ailawadi G; Hohmann SF; Thourani VH; Argenziano M; Alexander JH; Sankovic K; Gupta L; Blackstone EH; Acker MA; Russo MJ; Lee A; Burks SG; Gelijns AC; Bagiella E; Moskowitz AJ; Gardner TJ
    J Am Coll Cardiol; 2015 Jan; 65(1):15-23. PubMed ID: 25572505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of economic studies on surgical site infection.
    Yasunaga H; Ide H; Imamura T; Ohe K
    J Hosp Infect; 2007 Feb; 65(2):102-7. PubMed ID: 16978732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in analytical methodology for estimating costs of hospital-acquired infections: a systematic review.
    Fukuda H; Lee J; Imanaka Y
    J Hosp Infect; 2011 Feb; 77(2):93-105. PubMed ID: 21145131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries.
    Schrappe M; Lauterbach K
    AIDS; 1998; 12 Suppl A():S231-8. PubMed ID: 9633007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economic evaluation of an infection prevention and control program: are quality and patient safety programs worth the investment?
    Raschka S; Dempster L; Bryce E
    Am J Infect Control; 2013 Sep; 41(9):773-7. PubMed ID: 23993762
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.